MedPath

Studies on the inhibitory effect of DHA/EPA supplementation on immediate-type food allergic reactions

Not Applicable
Recruiting
Conditions
food allergy
Registration Number
JPRN-jRCTs031190192
Lead Sponsor
Ito Komei
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

1) Patients who tested positive for OFC in eggs (Boiled egg whites) and were instructed to completely remove them.
2) Patients aged between 3 and younger than 10
3) Patients who tasted a test food and are expected to consume it continuously for three months
4) Patients who can receive the test food once a week
5) Patients who are not allergic to milk

Exclusion Criteria

1) Patients who are taking supplements such as DHA containing food or probiotic food continuously.
2) Patients with TS score of 41 or higher induced by initial OFC (Patients for whom the safety of the evaluation OFC is not guaranteed)
3) Patients who have systemic diseases other than allergies
4) Patients who are judged by a physician to be unsuitable

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in ratio of Total score of Anaphylaxis scoring aichi (ASCA) divided by cumulative load protein.
Secondary Outcome Measures
NameTimeMethod
Change in plasma total lipid fatty acid fraction: Change in (EPA + DHA) / AA ratio<br>Change in total IgE value<br>Changes in specific IgE levels<br>Changes in intestinal flora analysis
© Copyright 2025. All Rights Reserved by MedPath